Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2022 How Should US Health Care Meet Latinx Community Health Needs? Chiamaka Sonubi, MD, Efren Flores, MD, and Lucy Spalluto, MD, MPH This commentary considers a grocery worker reluctant to be tested for SARS-CoV-2 and treated for COVID-19 out of fear of losing his livelihood. AMA J Ethics. 2022;24(4):E261-266. doi: 10.1001/amajethics.2022.261. Case and Commentary Apr 2022 ¿Cómo debe responder la atención médica estadounidense a las necesidades de salud de la comunidad latina? Chiamaka Sonubi, MD, Efren Flores, MD, and Lucy Spalluto, MD, MPH AMA J Ethics. 2022;E261-266. doi: 10.1001/amajethics.2022.261. Case and Commentary Jul 2009 Prohibitive Cost of HIV/AIDS Therapy in the United States Jennifer Cohn, MD Virtual Mentor. 2009;11(7):492-497. doi: 10.1001/virtualmentor.2009.11.7.ccas1-0907. Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 1 Francis A. Neelon, MD Virtual Mentor. 2004;6(12):529-531. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412. Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 2 Robert H. Pantell, MD Virtual Mentor. 2004;6(12):531-533. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412. Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 3 Timothy E. Quill, MD Virtual Mentor. 2004;6(12):533-535. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412. Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373.
Case and Commentary Apr 2022 How Should US Health Care Meet Latinx Community Health Needs? Chiamaka Sonubi, MD, Efren Flores, MD, and Lucy Spalluto, MD, MPH This commentary considers a grocery worker reluctant to be tested for SARS-CoV-2 and treated for COVID-19 out of fear of losing his livelihood. AMA J Ethics. 2022;24(4):E261-266. doi: 10.1001/amajethics.2022.261.
Case and Commentary Apr 2022 ¿Cómo debe responder la atención médica estadounidense a las necesidades de salud de la comunidad latina? Chiamaka Sonubi, MD, Efren Flores, MD, and Lucy Spalluto, MD, MPH AMA J Ethics. 2022;E261-266. doi: 10.1001/amajethics.2022.261.
Case and Commentary Jul 2009 Prohibitive Cost of HIV/AIDS Therapy in the United States Jennifer Cohn, MD Virtual Mentor. 2009;11(7):492-497. doi: 10.1001/virtualmentor.2009.11.7.ccas1-0907.
Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 1 Francis A. Neelon, MD Virtual Mentor. 2004;6(12):529-531. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412.
Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 2 Robert H. Pantell, MD Virtual Mentor. 2004;6(12):531-533. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412.
Case and Commentary Dec 2004 A Fever of Unknown Source, Commentary 3 Timothy E. Quill, MD Virtual Mentor. 2004;6(12):533-535. doi: 10.1001/virtualmentor.2004.6.12.ccas1-0412.
Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373.